Literature DB >> 19089458

Renal manifestations in toddlers with Takayasu's arteritis and malignant hypertension.

Rana Hijazi1, Jayanthi Chandar, Obioma Nwobi, Samina Muneeruddin, Gastón Zilleruelo, Carolyn L Abitbol.   

Abstract

Three children under the age of 3 years presented with malignant hypertension, proteinuria, and acute kidney injury. Takayasu's arteritis was diagnosed on the basis of clinical symptoms of weight loss and low grade fever in conjunction with elevated sedimentation rate and radiographic evidence of aortic and renal artery stenosis. One patient had a renal biopsy which showed arteriolar sclerosis and focal glomerulosclerosis. All three patients required multiple antihypertensive agents, ultimately including angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors. The vasculitis was treated with pulse corticosteroids followed by cyclophosphamide in one patient and mycophenolate mofetil as maintenance therapy in all. Follow-up has ranged from 2 to 8 years. Although global renal function has normalized in each patient, two have unilateral non-function of one kidney. The last patient has persistent aortic and renal artery stenosis with complex collateralization requiring ongoing medical and anticipated surgical management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089458     DOI: 10.1007/s00467-008-1088-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Angiographic features of 26 children with Takayasu's arteritis.

Authors:  Mignon McCulloch; Savvas Andronikou; Elizabeth Goddard; Paul Sinclair; John Lawrenson; Simone Mandelstam; Steve J Beningfield; Alastair J J W Millar
Journal:  Pediatr Radiol       Date:  2003-02-05

Review 2.  Takayasu's arteritis as a cause of renovascular hypertension in Asian countries.

Authors:  K S Chugh; V Sakhuja
Journal:  Am J Nephrol       Date:  1992       Impact factor: 3.754

3.  Angioplasty for renovascular hypertension in children: 20-year experience.

Authors:  Rukshana Shroff; Derek J Roebuck; Isky Gordon; Roger Davies; Suzanne Stephens; Stephen Marks; Mark Chan; Maria Barkovics; Clare A McLaren; Vanita Shah; Michael J Dillon; Kjell Tullus
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Renal artery stenosis and focal segmental glomerulosclerosis in the contralateral kidney.

Authors:  D Bhowmik; S C Dash; D Jain; S K Agarwal; S C Tiwari; A K Dinda
Journal:  Nephrol Dial Transplant       Date:  1998-06       Impact factor: 5.992

5.  Evaluation and long-term outcome of pediatric renovascular hypertension.

Authors:  S J McTaggart; S Gulati; R G Walker; H R Powell; C L Jones; S Gelati
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

6.  A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan.

Authors:  Fumihiko Takahashi; Naoyuki Hasebe; Junko Chinda; Motoi Okada; Toshiharu Takeuchi; Tomoya Hirayama; Chiiko Imamoto; Kenjiro Kikuchi
Journal:  Hypertens Res       Date:  2003-01       Impact factor: 3.872

7.  Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension.

Authors:  L G Navar; L M Harrison-Bernard
Journal:  Hypertens Res       Date:  2000-07       Impact factor: 3.872

8.  Childhood vasculitides in Turkey: a nationwide survey.

Authors:  Seza Ozen; Aysin Bakkaloglu; Ruhan Dusunsel; Oguz Soylemezoglu; Fatih Ozaltin; Hakan Poyrazoglu; Ozgur Kasapcopur; Ozan Ozkaya; Fatos Yalcinkaya; Ayse Balat; Nurdan Kural; Osman Donmez; Harika Alpay; Ali Anarat; Sevgi Mir; Ayfer Gur-Guven; Ferah Sonmez; Faysal Gok
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

9.  Takayasu arteritis in children.

Authors:  Nilgun Cakar; Fatos Yalcinkaya; Ali Duzova; Salim Caliskan; Aydan Sirin; Ayse Oner; Esra Baskin; Kenan Bek; Alper Soylu; Suat Fitoz; Aysun Karabay Bayazit; Zelal Bircan; Seza Ozen; Nermin Uncu; Mesiha Ekim
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

Review 10.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

View more
  7 in total

1.  Do classification criteria of Takayasu arteritis misdiagnose children with fibromuscular dysplasia?

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

2.  A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension.

Authors:  Kumiko Fukuda; Akira Shimizu; Tomohiro Kaneko; Yukinari Masuda; Fumihiko Yasuda; Megumi Fukui; Seiichiro Higo; Akio Hirama; Akiko Mii; Shuichi Tsuruoka; Ryuji Ohashi; Yasuhiko Iino; Yuh Fukuda; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-12-07

3.  Angioplasty for pediatric renovascular hypertension: a 13-year experience.

Authors:  Guangchang Zhu; Fuliang He; Yongquan Gu; Hengxi Yu; Bing Chen; Zhiwei Hu; Weitao Liang; Zhonggao Wang
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

Review 4.  Wind of Change in the Treatment of Childhood-Onset Takayasu Arteritis: a Systematic Review.

Authors:  Seher Sener; Ozge Basaran; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

5.  Biologics for childhood systemic vasculitis.

Authors:  Keiji Akamine; Marilynn Punaro
Journal:  Pediatr Nephrol       Date:  2018-09-10       Impact factor: 3.714

6.  Takayasu arteritis with an initial presentation of chronic monoarthritis mimicking oligoarticular juvenile idiopathic arthritis.

Authors:  Maynart Sukharomana; Sorawit Viravan; Nuntawan Piyaphanee; Sirirat Charuvanij
Journal:  Pediatr Rep       Date:  2018-07-09

7.  Aggressive progression of Takayasu's arteritis in infancy: a case report.

Authors:  Roman Pavić; Robert Blažeković; Dalibor Divković; Ksenija Marjanović; Mirna Sipl
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.780

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.